STOCK TITAN

Nice Ltd SEC Filings

NCSYF OTC Link

Welcome to our dedicated page for Nice SEC filings (Ticker: NCSYF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

The SEC filings page for NICE SYSTEMS LTD ORD (NCSYF) provides access to regulatory documents associated with NICE Ltd., a foreign private issuer that reports under the Securities Exchange Act of 1934. NICE Ltd. files annual reports on Form 20-F and furnishes event-driven information on Form 6-K, making these filings central sources of information for investors analyzing NCSYF.

Form 6-K current reports for NICE Ltd. include a range of exhibits, such as press releases on cloud revenue growth and revenue guidance, announcements of financial capital markets day webcasts, and GAAP financial statements that are incorporated by reference into numerous Form S-8 registration statements. Other 6-Ks furnish information on ESG performance, AI customer experience capabilities, contact center-related market assessments, partnerships, executive appointments and brand ambassador arrangements.

Certain Form 6-K filings also describe the results of the company’s annual general meeting of shareholders, including approval of proposals detailed in proxy statements previously submitted to the SEC. These documents, together with the Form 20-F annual reports, form the core regulatory record for NICE Ltd. and are key for understanding governance, financial reporting and corporate actions relevant to NCSYF.

On this filings page, users can review NICE Ltd.’s 6-K submissions and related materials as they appear in the SEC’s EDGAR system. AI-powered tools on the platform can help summarize lengthy filings, highlight key points in 10-K or 20-F style annual reports, clarify quarterly information contained in 6-Ks, and surface details from insider-related and equity compensation disclosures linked to Form S-8 references. This allows investors to navigate NICE Ltd.’s regulatory history more efficiently while focusing on the specific filing types and topics most relevant to their analysis of NCSYF.

Rhea-AI Summary

NICE Ltd. director Joseph Lamar Cowan filed an initial Form 3 detailing his equity stake in the company. He reports direct ownership of 4,769 Ordinary Shares, which includes 746 restricted stock units that vest under the terms of their awards, each representing one Ordinary Share.

Cowan also reports indirect ownership of 11,183 Ordinary Shares held by a corporation, and several option grants over Ordinary Shares. These stock options carry exercise prices ranging from $144.9030 to $232.2005 per share and expire between April 2026 and September 2031, with some fully vested and others scheduled to vest in installments during 2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

NICE Ltd. director David Kostman filed an initial Form 3 reporting his beneficial ownership. He directly holds 19,146 Ordinary Shares, which include 1,744 RSUs and 7,635 ADRs, each ADR representing one Ordinary Share. He also reports multiple option awards over Ordinary Shares, such as options exercisable for 14,920 shares at an exercise price of $151.63 expiring on April 30, 2026 and options for 10,423 shares at $224.18 expiring on September 10, 2026, along with additional grants extending through 2031. The filing records current holdings and does not show new purchases or sales.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

NICE Ltd. filed an initial Form 3 for director Dan Michael Falk, detailing his existing stock option holdings in the company’s ordinary shares. The filing lists multiple option awards with different exercise prices and expiration dates ranging from 2026 through 2031.

Some options, including grants covering ordinary shares at exercise prices such as 224.1800 and 144.9030, are fully vested and currently exercisable. One grant is already exercisable for 746 ordinary shares and is scheduled to vest in three substantially equal installments on March 30, 2026, June 30, 2026, and September 30, 2026. Another option grant will fully vest on September 30, 2026. The form records holdings only and does not report new purchases or sales.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

NICE Ltd. director Caroline J. Tsay filed an initial ownership report showing equity awards rather than new share purchases or sales. She holds options linked to 2,987 Ordinary Shares at an exercise price of $144.9030 per share, expiring on September 30, 2031. These options are already vested for 746 Ordinary Shares and will vest for the remaining shares in three substantially equal installments on March 30, 2026, June 30, 2026, and September 30, 2026. She also holds 746 Restricted Share Units, each representing a contingent right to receive one Ordinary Share, which will vest under the terms of the applicable awards.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

NICE Ltd. Chief Financial Officer Mary Beth Gaspich filed an initial ownership report showing her equity stake in the company. She directly holds 62,121 Ordinary Shares, which include 32,615 restricted stock units (RSUs) and 15,910 performance stock units (PSUs), each convertible into one Ordinary Share as they vest under their award terms. She also holds Performance Share Units representing a contingent right to receive 5,000 Ordinary Shares, eligible to vest over a three-year performance period ending February 18, 2029. These units may be earned between 0%-200% of target levels based on the company’s stock price performance against specified thresholds.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

NICE Ltd. executive Levy Meir Alon, VP, General Counsel & Corporate Secretary, reports holding stock options tied to 1,800 Ordinary Shares. These options carry an exercise price of 0.3108 and expire on November 11, 2031.

According to the vesting schedule, the option will vest in substantially equal installments on September 1, 2026, September 1, 2027, September 1, 2028 and September 1, 2029. This Form 3 serves as an initial statement of this derivative holding.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

NICE Ltd. furnished a Form 6-K highlighting two AI-focused milestones. First, its NiCE Cognigy platform was recognized as the only vendor to receive the Customers’ Choice distinction in the 2025 Gartner Peer Insights Voice of the Customer for Enterprise Conversational AI Platforms, based on verified user reviews and a 4.8/5 rating from 138 ratings as of January 14, 2026.

Second, NICE released The Agentic AI CX Frontline report, which shares live enterprise benchmarks for AI-first customer experience, including 3x faster deployments, containment rates exceeding 80%, double-digit reductions in cost per contact, and customer satisfaction gains of up to 20% for large organizations using Agentic AI at scale.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

NICE Ltd. filed its annual Form 20-F describing its business, share capital and extensive risk factors for the year ended December 31, 2025. The company reports 60,427,562 ordinary shares outstanding as of that date, excluding 14,347,265 treasury shares.

The filing highlights intense competition, rapid technology change including AI, reliance on cloud and third‑party infrastructure, and challenges shifting from on‑premises to SaaS and usage-based models. It also details cybersecurity and data-privacy exposure, regulatory and AI-related compliance risks, acquisition and integration risks, and financial risks such as foreign exchange volatility and dependence on tax benefits.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
annual report
-
Rhea-AI Summary

NICE reported an insider sale filing. A Form 144 entry lists 1,550 common shares associated with restricted stock vesting under a registered plan, with the transaction dated 02/19/2026. The filing identifies the broker as Morgan Stanley Smith Barney LLC and the market as NASDAQ.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
Rhea-AI Summary

NICE Ltd. reported solid fourth quarter and full-year 2025 results, led by strong cloud and AI-driven growth. Q4 revenue reached $786.5M, up 9%, with cloud revenue of $608.3M, up 14%. GAAP diluted EPS was $2.41, up 57%, and non-GAAP diluted EPS was $3.24, up 7%.

For 2025, total revenue was $2,945.4M, up 8%, and cloud revenue was $2,238.4M, up 13%. GAAP diluted EPS rose to $9.67, up 43%, while non-GAAP diluted EPS was $12.30, up 11%. AI annual recurring revenue grew 66% year over year to $328M, and AI was included in 100% of new seven-figure CXone deals.

Operating cash flow for 2025 was $716.5M, with free cash flow of $622.8M and $488.9M used for share repurchases. Year-end cash, cash equivalents and short-term investments totaled $417.4M with no outstanding debt. NICE entered a new $300M revolving credit facility maturing in 2029 and its board authorized a new $600M share repurchase program, bringing total remaining repurchase capacity to about $1B. For 2026, NICE guides to non-GAAP revenue of $3,170M–$3,190M (about 8% growth) and non-GAAP EPS of $10.85–$11.05, with cloud revenue expected to grow 14.5–15.0%.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report

FAQ

How many Nice (NCSYF) SEC filings are available on StockTitan?

StockTitan tracks 43 SEC filings for Nice (NCSYF), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Nice (NCSYF)?

The most recent SEC filing for Nice (NCSYF) was filed on March 18, 2026.

NCSYF Rankings

NCSYF Stock Data

6.87B
60.43M
Software - Application
Technology
Link
Israel
Ra'anana

NCSYF RSS Feed